THE ROLE OF HTA AGENCY IN DRUG REIMBURSEMENT DECISION-MAKING PROCESS IN POLAND (HTA IMPACT)

被引：2
|
作者：
Kolasa, K. [1 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74230-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A251 / A251
页数：1
相关论文
共 50 条
  • [41] SHOULD THE PATIENT VOICE HAVE AN ACTIVE ROLE IN HTA DECISION-MAKING? A PAG CONSENSUS ANALYSIS IN GREECE
    Naoum, V
    Naoum, P.
    Karampli, E.
    Athanasakis, K.
    Kyriopoulos, J.
    Pavi, E.
    VALUE IN HEALTH, 2019, 22 : S799 - S799
  • [42] IMPACT OF HEALTH CARE REFORM ON DRUG REIMBURSEMENT DECISION-MAKING IN TAIWAN
    Lai, L.
    Eccles, T.
    Heemstra, L.
    Van Engen, A.
    VALUE IN HEALTH, 2014, 17 (07) : A661 - A661
  • [43] BEST PRACTICES FOR ECA STUDY DESIGN TO SUPPORT HTA DECISION-MAKING IN EUROPE
    Dumuolin, O.
    Vidalis, A.
    Proenca, C.
    VALUE IN HEALTH, 2022, 25 (12) : S339 - S340
  • [44] CAN EARLY US ADOPTION OF CANCER DRUGS INFORM HTA DECISION-MAKING?
    Jonsson, P.
    Mpofu, P.
    Kent, S.
    Copeland, A.
    Groves, B.
    Bargo, D.
    Ramsey, S.
    Baxi, S.
    Adamson, B.
    VALUE IN HEALTH, 2021, 24 : S51 - S51
  • [45] CHARTING THE PROGRESS OF HTA IN ASIA: ARE WE READY FOR EVIDENCE BASED DECISION-MAKING?
    Kumar, R.
    Suharlim, C.
    Amaris, Caruso A.
    Gilmartin, C.
    Mehra, M.
    Castro, H.
    VALUE IN HEALTH, 2021, 24 : S186 - S186
  • [46] CHARACTERIZING EVIDENTIARY CRITIQUES IN HTA DECISION-MAKING FOR TREATMENTS INDICATED FOR OVERWEIGHT AND OBESITY
    O'Brien, M.
    Siamopoulou, E.
    Oshinbolu, S.
    Budhia, S.
    VALUE IN HEALTH, 2024, 27 (12) : S363 - S363
  • [47] Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
    Ascef, Bruna de Oliveira
    Leonel da Silva, Renan Goncalves
    de Oliveira Junior, Haliton Alves
    De Soarez, Patricia Coelho
    CADERNOS DE SAUDE PUBLICA, 2019, 35 (09):
  • [48] HTA decision-making for drugs for rare diseases: comparison of processes across countries
    Stafinski, Tania
    Glennie, Judith
    Young, Andrea
    Menon, Devidas
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [49] DRIVERS IN HTA DECISION-MAKING FOR CHOLESTEROL LOWERING PCSK9 INHIBITORS
    Kreeftmeijer, J.
    Dekkers, R.
    van Engen, A.
    VALUE IN HEALTH, 2016, 19 (07) : A603 - A603
  • [50] ROLE OF PATIENT INPUT IN THE CEDAC DRUG REIMBURSEMENT DECISION MAKING PROCESS
    Dionne, P. A.
    Weicker, S.
    Remple, V
    Tran, T.
    VALUE IN HEALTH, 2014, 17 (03) : A10 - A11
12345